Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dempsey

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
Internal Medicine Journal|March 22, 2019
Low positive predictive value of International Classification of Diseases, 10th Revision codes in relation to rheumatic heart disease: a challenge for global surveillanceJudith M Katzenellenbogen, Lee Nedkoff, Jeffrey Cannon, et al.
Medical and Pediatric Oncology|July 9, 1999
Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Lau, L C Ingram, et al.
Academic Radiology|December 2, 2006
Assessment of polyp and mass histopathology by intravenous contrast-enhanced CT colonographyRonald M Summers, Adam Huang, Jianhua Yao, et al.
Journal of Medicinal Chemistry|November 8, 1996
Potent and selective thrombin inhibitors incorporating the constrained arginine mimic l-3-piperidyl(N-guanidino)alanine at P1O E Levy, J E Semple, M L Lim, et al.
Journal of Rare Diseases (Berlin, Germany)|August 21, 2024
Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of IrelandM Vasseghi, C Behan, A Connolly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapyW S Lofters, J L Pater, B Zee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapyJ L Pater, W S Lofters, B Zee, et al.
BMC Medical Research Methodology|November 11, 2023
The development and acceptability of an educational and training intervention for recruiters to neonatal trials: the TRAIN projectV Smith, H Delaney, A Hunter, et al.
BMJ (Clinical Research Ed.)|August 14, 2021
Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial (PARROT Ireland)D Hayes-Ryan, A S Khashan, K Hemming, et al.
Assessment|December 21, 2018
Psychometric Properties of the Merrill-Palmer-Revised Scales of Development in Preschool Children With Autism Spectrum DisorderErin E Dempsey, Isabel M Smith, Helen E Flanagan, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
Internal Medicine Journal|March 22, 2019
Low positive predictive value of International Classification of Diseases, 10th Revision codes in relation to rheumatic heart disease: a challenge for global surveillanceJudith M Katzenellenbogen, Lee Nedkoff, Jeffrey Cannon, et al.
Medical and Pediatric Oncology|July 9, 1999
Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Lau, L C Ingram, et al.
Academic Radiology|December 2, 2006
Assessment of polyp and mass histopathology by intravenous contrast-enhanced CT colonographyRonald M Summers, Adam Huang, Jianhua Yao, et al.
Journal of Medicinal Chemistry|November 8, 1996
Potent and selective thrombin inhibitors incorporating the constrained arginine mimic l-3-piperidyl(N-guanidino)alanine at P1O E Levy, J E Semple, M L Lim, et al.
Journal of Rare Diseases (Berlin, Germany)|August 21, 2024
Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of IrelandM Vasseghi, C Behan, A Connolly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapyW S Lofters, J L Pater, B Zee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapyJ L Pater, W S Lofters, B Zee, et al.
BMC Medical Research Methodology|November 11, 2023
The development and acceptability of an educational and training intervention for recruiters to neonatal trials: the TRAIN projectV Smith, H Delaney, A Hunter, et al.
BMJ (Clinical Research Ed.)|August 14, 2021
Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial (PARROT Ireland)D Hayes-Ryan, A S Khashan, K Hemming, et al.
Assessment|December 21, 2018
Psychometric Properties of the Merrill-Palmer-Revised Scales of Development in Preschool Children With Autism Spectrum DisorderErin E Dempsey, Isabel M Smith, Helen E Flanagan, et al.
Pageof 27